Furthermore, our results reveal a potential molecular mechanism by which E2F8 promotes cell proliferation and tumorigenicity in breast cancer, via transcriptionally activating the CCNE1, and CCNE2 promoters. This evidence concerns the gene CCNE2 and breast cancer.